$1.950
+0.441 (+22.64%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
NBY Prediction & Forecast by Similar Chart Analysis
Alphio's NBY stock price prediction model matches the current NovaBay Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.95 (+0.12%). The 1-week path is $1.97 (+0.96%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy NovaBay Pharmaceuticals Inc Stock?
NovaBay Pharmaceuticals Inc (NBY) is not a strong buy for a beginner investor seeking long-term growth. Despite the recent price surge, the lack of positive financial performance, absence of strong trading signals, and neutral sentiment from hedge funds and insiders suggest that this stock does not align with the user's investment goals.
NBY stock price ended at $1.95 on Thursday, after rising +22.64%
NovaBay Pharmaceuticals Inc (NBY) last closed at $1.95, gaining +22.64%. These facts feed the 1-day and 1-week NBY price prediction above.
Analyst Consensus
NovaBay Pharmaceuticals Inc (NBY): 4 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
NovaBay Pharmaceuticals Inc (NBY) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches NBY, ranked by similarity.
Seasonality analysis for NBY
Historically the probability of a positive August return for NBY is 18.60%. September offers the highest probability of a positive month at 51.22%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for NBY
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $0.41 | $0.44 | $0.50 | -77.62% |
| Sep 2026 | $0.22 | $0.36 | $0.50 | -81.66% |
| Oct 2026 | $0.49 | $0.51 | $0.61 | -73.93% |
| Nov 2026 | $0.45 | $0.46 | $0.57 | -76.66% |
| Dec 2026 | $0.30 | $0.41 | $0.46 | -78.89% |
In 2026, NovaBay Pharmaceuticals Inc (NBY) is projected to range from $0.22 to $0.61.
NovaBay Pharmaceuticals Inc 2026 monthly forecast
In Aug 2026, NovaBay Pharmaceuticals Inc is projected to average $0.44, with a low of $0.41 and high of $0.50.
In Sep 2026, NovaBay Pharmaceuticals Inc is projected to average $0.36, with a low of $0.22 and high of $0.50.
In Oct 2026, NovaBay Pharmaceuticals Inc is projected to average $0.51, with a low of $0.49 and high of $0.61.
In Nov 2026, NovaBay Pharmaceuticals Inc is projected to average $0.46, with a low of $0.45 and high of $0.57.
In Dec 2026, NovaBay Pharmaceuticals Inc is projected to average $0.41, with a low of $0.30 and high of $0.46.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.